Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://www.primetherapeutics.com/w/prime-therapeutics-leader-pat-gleason-named-2026-pbmi-innovator Example Link

Awards

Prime Therapeutics leader Pat Gleason named 2026 PBMI Innovator

August 12, 2026

https://www.primetherapeutics.com/w/managed-healthcare-executive-pbmi-innovator-patrick-gleason-pharm.d. https://www.managedhealthcareexecutive.com/view/pbmi-innovator-patrick-gleason-pharm-d-

In the News

Managed Healthcare Executive: PBMI Innovator Patrick Gleason, Pharm.D.

August 13, 2026

https://www.primetherapeutics.com/w/prime-therapeutics-leader-pat-gleason-named-2026-pbmi-innovator

Stories

Prime Therapeutics leader Pat Gleason named 2026 PBMI Innovator

August 12, 2026

https://www.primetherapeutics.com/w/quarterly-drug-pipeline-july-2026 /quarterly-drug-pipeline-july-2026

Research & Publications

Quarterly Drug Pipeline: July 2026

August 07, 2026

The Latest

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-therapeutics-delivers-more-than-100-million-in-savings-by-improving-care-coordination-and-reducing-treatment-delays-for-cancer-and-cystic-fibrosis-patients

Prime Therapeutics delivers more than $100 million in savings by improving care coordination and reducing treatment delays for cancer and cystic fibrosis patients

March 10, 2026

https://www.primetherapeutics.com/w/prime-therapeutics-appoints-public-affairs-veteran-katie-payne-as-chief-external-affairs-officer

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

November 13, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-supports-fda-s-updated-biosimilar-recommendations

Prime Therapeutics supports FDA’s updated biosimilar recommendations

October 30, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-to-present-latest-managed-care-pharmacy-insights-at-amcp-nexus-2025

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

October 27, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-scales-judi-platform-implementations-with-support-from-pwc

Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

October 01, 2025

https://www.primetherapeutics.com/w/what-s-driving-medical-benefit-spend-prime-therapeutics-trend-report-shares-new-clues

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

September 04, 2025

Showing 1 to 6 of 42

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/11-major-drug-decisions-anticipated-in-early-2026

11 major drug decisions anticipated in early 2026

February 27, 2026

https://www.primetherapeutics.com/w/in-case-you-missed-it-trends-in-recent-fda-approved-treatments

In case you missed it: Trends in recent FDA-approved treatments

February 27, 2026

https://www.primetherapeutics.com/w/payers-play-an-evolving-role-in-small-cell-lung-cancer-treatment

Payers play an evolving role in small cell lung cancer treatment

December 23, 2025

https://www.primetherapeutics.com/w/inflammatory-bowel-disease-at-the-crossroads-of-medical-and-pharmacy

Inflammatory bowel disease at the crossroads of medical and pharmacy

November 25, 2025

https://www.primetherapeutics.com/w/end-of-year-outlook-what-s-next-for-drug-approvals-pipeline-and-innovation

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

November 10, 2025

https://www.primetherapeutics.com/w/integrated-oncology-insights-navigating-the-medical-and-pharmacy-claims-landscape

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

October 23, 2025

Showing 1 to 6 of 71

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-therapeutics-leader-pat-gleason-named-2026-pbmi-innovator

Prime Therapeutics leader Pat Gleason named 2026 PBMI Innovator

August 12, 2026

https://www.primetherapeutics.com/w/making-migraine-treatment-easier-to-navigate

Making migraine treatment easier to navigate

June 11, 2026

https://www.primetherapeutics.com/w/what-payers-need-to-know-about-accelerated-drug-approvals

What payers need to know about accelerated drug approvals

June 10, 2026

https://www.primetherapeutics.com/w/managed-healthcare-executive-recognizes-prime-s-zach-jones-as-a-2026-emerging-leader-in-healthcare

Managed Healthcare Executive recognizes Prime’s Zach Jones as a 2026 Emerging Leader in Healthcare

June 09, 2026

https://www.primetherapeutics.com/w/how-prime-s-integratedrx-helps-payers-manage-high-cost-cystic-fibrosis-drugs-by-reducing-handoffs-and-speeding-access-to-therapy

How Prime’s IntegratedRx® helps payers manage high-cost cystic fibrosis drugs by reducing handoffs and speeding access to therapy

May 26, 2026

https://www.primetherapeutics.com/w/prime-employees-recognized-with-national-culture-and-inclusion-award

Prime employees recognized with national culture and inclusion award

May 14, 2026

Showing 1 to 6 of 205

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-presents-at-73rd-annual-roy-a-bowers-pharmaceutical-conference-on-nov-11

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

October 29, 2025

https://www.primetherapeutics.com/w/prime-presents-at-hlth-usa-conference-on-oct-20

Prime presents at HLTH USA conference on Oct. 20

October 17, 2025

https://www.primetherapeutics.com/w/prime-presents-2025-medical-pharmacy-trend-report-webcast-on-oct-13

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

September 23, 2025

https://www.primetherapeutics.com/w/prime-expert-presents-at-the-most-favored-nation-mandate-webinar

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

September 02, 2025

https://www.primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

https://www.primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

Showing 1 to 6 of 37

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/managed-healthcare-executive-pbmi-innovator-patrick-gleason-pharm.d. https://www.managedhealthcareexecutive.com/view/pbmi-innovator-patrick-gleason-pharm-d-

Managed Healthcare Executive: PBMI Innovator Patrick Gleason, Pharm.D.

August 13, 2026

https://www.primetherapeutics.com/w/realclear-health-the-question-we-should-be-asking-about-drug-costs https://www.realclearhealth.com/articles/2026/07/30/the_question_we_should_be_asking_about_drug_costs_1197545.html

RealClearHealth: The Question We Should Be Asking About Drug Costs

July 30, 2026

https://www.primetherapeutics.com/w/managed-healthcare-executive-zach-jones-pharm.d.-%7C-2026-mhe-emerging-leaders-in-healthcare https://www.managedhealthcareexecutive.com/view/zach-jones-pharm-d-2026-mhe-emerging-leaders-in-healthcare

Managed Healthcare Executive: Zach Jones, Pharm.D. | 2026 MHE Emerging Leaders in Healthcare

June 01, 2026

https://www.primetherapeutics.com/w/ajmc-amcp-2026-highlights-managed-care-trends-in-oncology-policy-and-innovation

AJMC: AMCP 2026 Highlights: Managed Care Trends in Oncology, Policy, and Innovation

April 23, 2026

https://www.primetherapeutics.com/w/managed-healthcare-executive-facing-the-practical-problems-of-gene-therapy-%7C-amcp-annual-2026 https://www.managedhealthcareexecutive.com/view/facing-the-practical-problems-of-gene-therapy-amcp-annual-2026

Managed Healthcare Executive: Facing the practical problems of gene therapy | AMCP Annual 2026

April 23, 2026

https://www.primetherapeutics.com/w/managed-healthcare-executive-pharmacogenomic-testing-becomes-standard-in-oncology-care-amid-new-guidelines https://www.managedhealthcareexecutive.com/shorts/pharmacogenomic-testing-becomes-standard-in-oncology-care-amid-new-guidelines

Managed Healthcare Executive: Pharmacogenomic testing becomes standard in oncology care amid new guidelines

April 20, 2026

Showing 1 to 6 of 154

Categories

PA Research & Publications

https://www.primetherapeutics.com/w/quarterly-drug-pipeline-july-2026 /quarterly-drug-pipeline-july-2026

Quarterly Drug Pipeline: July 2026

August 07, 2026

https://www.primetherapeutics.com/w/quarterly-drug-approvals-july-2026 /quarterly-drug-approvals-july-2026

Quarterly Drug Approvals: July 2026

August 03, 2026

https://www.primetherapeutics.com/w/trending-topics-drug-approvals-july-2026 /trending-topics-drug-approvals-july-2026

Oncology Insights: July 2026

July 24, 2026

https://www.primetherapeutics.com/w/fda-decisions-expected-august-2026 /fda-decisions-expected-august-2026

FDA Decisions Expected: August 2026

July 21, 2026

https://www.primetherapeutics.com/w/summer-2026-prime-therapeutics-report /summer-2026-prime-therapeutics-report

Summer 2026 Prime Therapeutics Report

July 16, 2026

Showing 1 to 6 of 241

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

Prime Therapeutics leader Pat Gleason named 2026 PBMI Innovator

Managed Healthcare Executive: PBMI Innovator Patrick Gleason, Pharm.D.

Prime Therapeutics leader Pat Gleason named 2026 PBMI Innovator

Quarterly Drug Pipeline: July 2026

The Latest

Prime Therapeutics delivers more than $100 million in savings by improving care coordination and reducing treatment delays for cancer and cystic fibrosis patients

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

Prime Therapeutics supports FDA’s updated biosimilar recommendations

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

11 major drug decisions anticipated in early 2026

In case you missed it: Trends in recent FDA-approved treatments

Payers play an evolving role in small cell lung cancer treatment

Inflammatory bowel disease at the crossroads of medical and pharmacy

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

Prime Therapeutics leader Pat Gleason named 2026 PBMI Innovator

Making migraine treatment easier to navigate

What payers need to know about accelerated drug approvals

Managed Healthcare Executive recognizes Prime’s Zach Jones as a 2026 Emerging Leader in Healthcare

How Prime’s IntegratedRx® helps payers manage high-cost cystic fibrosis drugs by reducing handoffs and speeding access to therapy

Prime employees recognized with national culture and inclusion award

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

Prime presents at HLTH USA conference on Oct. 20

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

Prime presents at ISG Digital Business Summit on Nov. 14

Managed Healthcare Executive: PBMI Innovator Patrick Gleason, Pharm.D.

RealClearHealth: The Question We Should Be Asking About Drug Costs

Managed Healthcare Executive: Zach Jones, Pharm.D. | 2026 MHE Emerging Leaders in Healthcare

AJMC: AMCP 2026 Highlights: Managed Care Trends in Oncology, Policy, and Innovation

Managed Healthcare Executive: Facing the practical problems of gene therapy | AMCP Annual 2026

Managed Healthcare Executive: Pharmacogenomic testing becomes standard in oncology care amid new guidelines

Quarterly Drug Pipeline: July 2026

Quarterly Drug Approvals: July 2026

Trending Topics & Drug Approvals: July 2026

Oncology Insights: July 2026

FDA Decisions Expected: August 2026

Summer 2026 Prime Therapeutics Report

Login Portals

Compliance / Legal

Company